These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3450178)

  • 1. [Anti-arrhythmic effects of morlincain].
    Zhang YL; Rui YC; Tu SZ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):417-20. PubMed ID: 3450178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Reznikov AIu; Galygo DS; Bartashevich VV
    Biull Eksp Biol Med; 1996 Dec; 122(12):665-8. PubMed ID: 9280469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
    Chen JC; Min Y; Pan XX
    Zhongguo Yao Li Xue Bao; 1988 Mar; 9(2):132-6. PubMed ID: 3188948
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmia properties of marcaine].
    Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
    Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiarrhythmic effects of anisodamine].
    Chen JM; Gu SL
    Yao Xue Xue Bao; 1988 Nov; 23(11):857-9. PubMed ID: 3257043
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia].
    Gu CG; Chen WZ; Dong YL; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):173-7. PubMed ID: 6239508
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of anti-arrhythmic activities of valproic acid derivatives in animals].
    Jia HJ; Liu X; Yan YF; Ye YW
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):37-40. PubMed ID: 3142209
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local anesthetics and their quaternary derivatives as anti-arrhythmia agents].
    Gendenshteĭn EI; Tsybusov AP
    Farmakol Toksikol; 1985; 48(1):112-7. PubMed ID: 2579846
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivatives of (R,S)-1-N-(theophyllinyl-7'-ethyl)-amino-2-propanol with antiarrhythmic activity.
    Eckstein M; Zajaczkowska J; Samochowiec L; Maksjan M
    Pol J Pharmacol Pharm; 1990; 42(4):387-92. PubMed ID: 2097599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on local anesthetics. LVIII. Comparison of the anti-arrhythmia effect of heptacaine and lidocaine].
    Kozlovský J; Cizmárik J; Pesak M; Borovanský A
    Cesk Farm; 1976 Jul; 25(6):218-21. PubMed ID: 975263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of lorcainide on experimental arrhythmias in comparison with other antiarrhythmic agents].
    Ma X; Li ZW
    Yao Xue Xue Bao; 1986 Apr; 21(4):241-5. PubMed ID: 3788590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of thioproline on experimental arrhythmia].
    Zhao HP; Feng GH
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):30-2. PubMed ID: 6232816
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of the anti-arrhythmic activity of cimetidine in anesthetized guinea pigs].
    Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):50-3. PubMed ID: 2876579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the mechanisms of the anti-arrhythmic action of marcaine and lidocaine].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu; Dzhaparidze MM
    Farmakol Toksikol; 1984; 47(3):46-50. PubMed ID: 6734807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiarrhythmic activity of lidocaine under conditions of lipid and carbohydrate metabolisms disturbances in modeling early occlusional and reperfusional arrhythmias].
    Artem'eva OV; Koriaĭ kina AV; Zor'kina AV
    Eksp Klin Farmakol; 2007; 70(1):22-5. PubMed ID: 17402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrillatory, cardiovascular and toxic effects of sparteine, butylsparteine and pentylsparteine.
    Zetler G; Strubelt O
    Arzneimittelforschung; 1980; 30(9):1497-502. PubMed ID: 7193016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.